May 5, 2026 04:20AM

Apr 28, 2026 09:13AM

Apr 10, 2026 09:31AM

Apr 1, 2026 12:10PM

Mar 25, 2026 06:07AM

Mar 13, 2026 06:02AM

Feb 24, 2026 09:04AM Wolfe Research Starts Axsome Therapeutics (AXSM) at Outperform

Feb 24, 2026 05:40AM

Feb 23, 2026 12:32PM

Feb 23, 2026 12:17PM

Feb 23, 2026 07:00AM

Jan 13, 2026 04:52AM

Jan 8, 2026 03:37AM

Jan 5, 2026 06:40AM Axsome Therapeutics (AXSM) PT Raised to $200 at H.C. Wainwright

Jan 2, 2026 08:53AM

Jan 2, 2026 06:23AM

Dec 31, 2025 01:54PM

Dec 31, 2025 01:20PM

Dec 31, 2025 01:19PM

Dec 31, 2025 12:42PM

Dec 31, 2025 08:25AM Truist on Axsome Therapeutics (AXSM): 'We fully expect ADA to be a significantly larger opportunity for AXS-05'

Dec 31, 2025 08:24AM

Dec 31, 2025 07:00AM

Dec 31, 2025 07:00AM

Dec 31, 2025 06:55AM

Dec 31, 2025 06:55AM

Jan 13, 2025 12:50PM

Dec 16, 2024 07:03AM RBC Capital's Global Biotech Outlook Report: 'Top 2025 Ideas'

Nov 26, 2024 07:00AM

Nov 26, 2024 07:00AM

Nov 12, 2024 07:00AM

Sep 5, 2024 06:48AM

Sep 4, 2024 07:01AM

Sep 4, 2024 07:00AM

Apr 30, 2024 09:00PM AXSOME ALERT: Bragar Eagel & Squire, P.C. is Investigating Axsome Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Apr 17, 2024 09:00PM

Apr 12, 2024 02:30AM

Apr 3, 2024 09:00PM

Mar 25, 2024 09:00PM

Mar 25, 2024 06:31AM

Mar 25, 2024 06:30AM

Aug 19, 2022 10:39AM Cowen Reiterates Outperform, $130 PT on Axsome Therapeutics (AXSM) Following FDA Approval

Jul 4, 2022 09:00PM

Jun 29, 2022 09:00PM

Jun 24, 2022 09:00PM

Jun 19, 2022 09:00PM

Jun 13, 2022 09:00PM

Jun 8, 2022 09:00PM

Jun 3, 2022 09:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Oscar Health, Axsome, Humbl, and Okta and Encourages Investors to Contact the Firm

Jun 2, 2022 08:10AM

15,425 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All